• Dr. Sangeeta Kamthan

In recent years, the number of commercially avail- able antiepileptic drugs (aeds) has increased steadily. This may make management decisions more difficult, but it also presents some welcome new options for efficiently individualising care. Opportunities to customise drug treatment to the unique patient's characteristics have never been stronger due to the fact that each of the available aeds differs from others in a number of therapeutically significant aspects. Spectrum of efficacy in various seizure types, adverse effects profile, pharmacokinetic properties, susceptibility to cause or be a target of clinically important drug-drug interactions, ease of use, and cost are all factors that should be taken into consideration when choosing a drug for patients with epilepsy. It is also important to take into account the accessibility of user-friendly paediatric formulations and any potential positive effects on co-morbid conditions when selecting a medicine. In fact, a number of aeds, notably those used to treat psychiatric disorders, prevent migraines, and treat neuropathic pain, are effective and frequently used for other purposes. Recent years have seen improvements in our understanding of the molecular mechanisms underlying the effects of drugs. Even if a fully mechanistic approach to the clinical use of these medications is not currently practical, understanding their mechanisms of action can help predict their efficacy profile and range of potential side effects.

Synthesis of Anti –epileptic Drug

"Synthesis of Anti –epileptic Drug", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.2, Issue 8, page no.965-971, August-2015, Available :http://www.jetir.org/papers/JETIR1701838.pdf

"Synthesis of Anti –epileptic Drug", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.2, Issue 8, page no. pp965-971, August-2015, Available at : http://www.jetir.org/papers/JETIR1701838.pdf